亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

云南思摩貝特生物科技有限公司  

有機(jī)化學(xué)原料的研發(fā),生產(chǎn),銷售

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人:馮雪蘭
  • 電話:0871-68352571
  • 郵件:2318848591@qq.com
  • 傳真:0871-68319152
  • QQ:2318848591
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > 供應(yīng)大量多索茶堿
供應(yīng)大量多索茶堿
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 云南昆明市付款后3天內(nèi)
型號(hào) 69975-86-6
規(guī)格 99%以上
過(guò)期 長(zhǎng)期有效
更新 2013-09-16 16:01
 
詳細(xì)信息

中文名稱: 多索茶堿
中文同義詞: 1,3-二甲基-7-(1,3-二氧環(huán)戊基-2-基)甲基-3,7-二氫-1H-嘌呤-2,6-二酮;多索茶堿;多沙茶堿;2-(7'-茶堿甲基)-1,3-二氧戊環(huán)
英文名稱: Doxofylline
英文同義詞: DOXOFYLLINE;DOXOPHYLLINE;7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione;2-(7’-teofillinmetil)-1,3-diossolano;2-(7’-theophyllinemethyl)-1,3-dioxolane;3,7-dihydro-7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-1h-purine-6-dione;7-(1,3-dioxolan-2-ylmethyl)-theophyllin;7-(1,3-dioxolan-2-ylmethyl)theophylline
CAS號(hào): 69975-86-6
分子式: C11H14N4O4
分子量: 266.25
EINECS號(hào): 274-239-6
相關(guān)類別: 呼吸系統(tǒng)藥物;醫(yī)藥與生物化工;呼吸系統(tǒng)用藥;平喘藥;藥物
   
 
©2025 云南思摩貝特生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:13019  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |